Six years ago, during the study of the entrepreneurship competition at the university, Valentina Agudelo identified a disturbing gap in the experience of breast cancer between Latin America and the developed world: women in her hometown Colombia and the rest of South America die at a higher pace because of late detection.
Today, Agudelo is a co -founder and general director of Salva Health, and recently received the essential prize at the Battleffield startup field in TechCrunch. In the latest episode of Equity, he joins Rebecter Bellan to debate how her company uses the Juliet screening device to revolutionize early detection of breast cancer.
But before we delve into it, a quick reminder: the applications are now open to this 12 months’s competition, so make sure take yours!
Listen to the full episode to listen to more about:
- How the flagship product Salva Health, Julieta, makes early detection of breast cancer more accessible and efficient in distant locations.
- A singular model of equipment as a service and its impact on rural health care.
- Salva Health expansion plans and testing other diseases, similar to osteoporosis and liver cancer.
- Challenges related to making sure the financing of startups run by women.
- Agudelo experience competing in the startup field of the TechCrunch battle and suggestions for future competitors!